Cambridge Nutritional Sciences PLC
LSE:CNSL

Watchlist Manager
Cambridge Nutritional Sciences PLC Logo
Cambridge Nutritional Sciences PLC
LSE:CNSL
Watchlist
Price: 2 GBX Market Closed
Market Cap: £4.8m

Relative Value

The Relative Value of one CNSL stock under the Base Case scenario is 1.62 GBX. Compared to the current market price of 2 GBX, Cambridge Nutritional Sciences PLC is Overvalued by 19%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CNSL Relative Value
Base Case
1.62 GBX
Overvaluation 19%
Relative Value
Price
Worst Case
Base Case
Best Case

Multiples Across Competitors

CNSL Competitors Multiples
Cambridge Nutritional Sciences PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
Cambridge Nutritional Sciences PLC
LSE:CNSL
4.8m GBP 0.6 3.5 13.6 -2.3
JP
Hoya Corp
TSE:7741
9.1T JPY 9.9 36.4 26.3 31.5
US
Medline Inc
NASDAQ:MDLN
58.5B USD 0 0 0 0
CH
Alcon AG
SIX:ALC
30.3B CHF 3.8 37.4 15.4 30.1
DK
Coloplast A/S
CSE:COLO B
120.8B DKK 4.3 33.2 15.3 18.2
US
Align Technology Inc
NASDAQ:ALGN
12.8B USD 3.2 33.8 15.4 19.5
UK
ConvaTec Group PLC
LSE:CTEC
4.6B GBP 2.7 29.7 13.2 21.4
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
42.9B CNY 9.4 26 23.5 23.5
CA
Bausch + Lomb Corp
NYSE:BLCO
5.9B USD 1.2 -19.2 19.3 91
CH
Ypsomed Holding AG
SIX:YPSN
4.1B CHF 5.1 20.7 13.4 18.2
KR
HLB Inc
KOSDAQ:028300
7.2T KRW 89.4 -32.8 -76 -71.9
P/E Multiple
Earnings Growth PEG
UK
Cambridge Nutritional Sciences PLC
LSE:CNSL
Average P/E: 27.6
3.5
N/A N/A
JP
Hoya Corp
TSE:7741
36.4
13%
2.8
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
CH
Alcon AG
SIX:ALC
37.4
25%
1.5
DK
Coloplast A/S
CSE:COLO B
33.2
22%
1.5
US
Align Technology Inc
NASDAQ:ALGN
33.8
27%
1.3
UK
ConvaTec Group PLC
LSE:CTEC
29.7
33%
0.9
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
26
9%
2.9
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -19.2 N/A N/A
CH
Ypsomed Holding AG
SIX:YPSN
20.7
32%
0.6
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -32.8 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
UK
Cambridge Nutritional Sciences PLC
LSE:CNSL
Average EV/EBITDA: 17.3
13.6
N/A N/A
JP
Hoya Corp
TSE:7741
26.3
11%
2.4
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
CH
Alcon AG
SIX:ALC
15.4
8%
1.9
DK
Coloplast A/S
CSE:COLO B
15.3
8%
1.9
US
Align Technology Inc
NASDAQ:ALGN
15.4
13%
1.2
UK
ConvaTec Group PLC
LSE:CTEC
13.2
10%
1.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23.5
15%
1.6
CA
Bausch + Lomb Corp
NYSE:BLCO
19.3
21%
0.9
CH
Ypsomed Holding AG
SIX:YPSN
13.4
21%
0.6
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -76 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
UK
Cambridge Nutritional Sciences PLC
LSE:CNSL
Average EV/EBIT: 31.7
Negative Multiple: -2.3
N/A N/A
JP
Hoya Corp
TSE:7741
31.5
N/A N/A
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
CH
Alcon AG
SIX:ALC
30.1
23%
1.3
DK
Coloplast A/S
CSE:COLO B
18.2
8%
2.3
US
Align Technology Inc
NASDAQ:ALGN
19.5
16%
1.2
UK
ConvaTec Group PLC
LSE:CTEC
21.4
22%
1
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23.5
11%
2.1
CA
Bausch + Lomb Corp
NYSE:BLCO
91
60%
1.5
CH
Ypsomed Holding AG
SIX:YPSN
18.2
29%
0.6
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -71.9 N/A N/A